Page last updated: 2024-10-16

2,3-butylene glycol and Epilepsy

2,3-butylene glycol has been researched along with Epilepsy in 1 studies

2,3-butylene glycol: RN given refers to cpd without isomeric designation
butane-2,3-diol : A butanediol in which hydroxylation is at C-2 and C-3.

Epilepsy: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yu, DK1
Sawchuk, RJ1

Other Studies

1 other study available for 2,3-butylene glycol and Epilepsy

ArticleYear
Gas-liquid chromatographic determination of propylene glycol in plasma and urine.
    Clinical chemistry, 1983, Volume: 29, Issue:12

    Topics: Butylene Glycols; Chromatography, Gas; Epilepsy; Flame Ionization; Humans; Phenytoin; Propylene Glyc

1983